Patents by Inventor Maurizio Dalle Carbonare

Maurizio Dalle Carbonare has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical formulation containing palmitoyl ethanolamide and stearoyl ethanolamide
    Patent number: 8487007
    Abstract: The invention concerns new pharmaceutical formulations containing a blend of palmitoyl ethanolamide or PEA and stearoyl ethanolamide or SEA compounds as active principles. The formulation is suitable for oral, parenteral, topical, transdermic, rectal, sublingual, nasal, topical, transdermic, rectal, nasal or sublingual administration, whereby the dosage form of said formulations can be in patches, suppositories, ovules, pessaries, aerosol or spray, emulsions, suspensions, solutions.
    Type: Grant
    Filed: April 28, 2008
    Date of Patent: July 16, 2013
    Assignee: Vermont Italia SRL
    Inventor: Maurizio Dalle Carbonare
  • Use of hyaluronic acid derivatives in pharmaceutical preparations and biomaterials for the prevention and treatment of cutaneous scars
    Patent number: 8147811
    Abstract: Use of hyaluronic acid derivatives for the preparation of biomaterials for the prevention of the formation and the treatment of cutaneous scars, wherein the hyaluronic acid derivatives are optionally combined with pharmacologically or biologically active compounds.
    Type: Grant
    Filed: June 29, 2000
    Date of Patent: April 3, 2012
    Assignee: Fidia Farmaceutici S.p.A.
    Inventors: Maurizio Dalle Carbonare, Lanfranco Callegaro
  • Pharmaceutical formulation containing palmitoyl ethanolamide and stearoyl ethanolamide
    Publication number: 20110046225
    Abstract: The invention concerns new pharmaceutical formulations containing a blend of palmitoyl ethanolamide or PEA and stearoyl ethanolamide or SEA compounds as active principles. The formulation is suitable for oral, parenteral, topical, transdermic, rectal, sublingual, nasal, topical, transdermic, rectal, nasal or sublingual administration, whereby the dosage form of said formulations can be in patches, suppositories, ovules, pessaries, aerosol or spray, emulsions, suspensions, solutions.
    Type: Application
    Filed: April 28, 2008
    Publication date: February 24, 2011
    Applicant: VERMONT ITALIA SRL
    Inventor: Maurizio Dalle Carbonare
  • Three-dimensional structures containing hyaluronic acid derivatives obtained by the supercritical antisolvent technique
    Patent number: 7087745
    Abstract: Biocompatible and biodegradable, three-dimensional structures containing hyaluronic acid derivatives, obtained by the technique of precipitation induced by supercritical antisolvent (SAS), can be used in the field of medicine and surgery.
    Type: Grant
    Filed: April 6, 2000
    Date of Patent: August 8, 2006
    Assignee: Fidia Farmaceutici S.p.A.
    Inventors: Paolo Pallado, Marco Baggio, Maurizio Dalle Carbonare, Lanfranco Callegaro
  • Process for the preparation of autocrosslinked compounds of hyaluronic acid and the derivatives thereof by the supercritical antisolvent technique
    Patent number: 6552184
    Abstract: Crosslinked compounds of hyaluronic acid and the derivatives thereof, prepared by the technique of precipitation induced by supercritical antisolvent (SAS), can be used to advantage for the preparation of biomaterials for use in the field of medicine and surgery and in tissue engineering for medical and surgical purposes.
    Type: Grant
    Filed: November 14, 2001
    Date of Patent: April 22, 2003
    Assignee: Fidia Advanced Biopolymer s.r.l.
    Inventors: Paolo Pallado, Marco Baggio, Maurizio Dalle Carbonare, Lanfranco Callegaro